Cite
Jung YJ, Oh Y, Sujata P, et al. Assessment of the reporting quality of randomised controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: A Systematic Review. Clin Microbiol Infect. 2022;doi: 10.1016/j.cmi.2021.12.016.
Jung, Y. J., Oh, Y., Sujata, P., Jeong, H., & Kim, E. (2022). Assessment of the reporting quality of randomised controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: A Systematic Review. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, . https://doi.org/10.1016/j.cmi.2021.12.016
Jung, Youn-Joo, et al. "Assessment of the reporting quality of randomised controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: A Systematic Review." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. (2022). doi: https://doi.org/10.1016/j.cmi.2021.12.016
Jung YJ, Oh Y, Sujata P, Jeong H, Kim E. Assessment of the reporting quality of randomised controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: A Systematic Review. Clin Microbiol Infect. 2022 Jan 06; doi: 10.1016/j.cmi.2021.12.016. Epub 2022 Jan 06. PMID: 34999174; PMCID: PMC8733238.
Copy
Download .nbib